Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

There is endless profit potential to treat chronic diseases

Hans Duvefelt, MD
Conditions
August 8, 2020
Share
Tweet
Share

I have noticed several articles describing how antibiotic development has bankrupted some pharmaceutical companies because there isn’t enough potential profit in a ten-day course to treat multi-resistant superbug infections.

Chronic disease treatments, on the other hand, appear to be extremely profitable. A single month’s treatment with the newer diabetes drugs, COPD inhalers, or blood thinners costs over $500, which means well over $50,000 over an effective ten year patent for each one of an ever-increasing number of chronically ill patients.

Imagine if the same bureaucratic processes insurance companies have created for chronic disease drug coverage existed (I don’t know if they do) for acute prescriptions of superbug antibiotics: It’s Friday afternoon, and a septic patient’s culture comes back indicating that the only drug that would work is an expensive one that requires a prior authorization. Patients would die, and the insurance companies would be better off if time ran out in such bureaucratic battles for survival.

Suddenly it’s perfectly clear: There is endless profit potential for countless corporations in America’s chronic disease epidemic, and it is in their interest that people with chronic disease stay as sick as possible without dying from their disease. Why risk research money on acute disease when there is no continuing revenue stream to look forward to?

If people did all the things we know could improve their health, pharmaceutical companies, insurance companies, pharmacy benefit managers, and many others would go out of business, just like shopping malls and print media companies.

Where are the disrupters in health care? Will the perverse motives of the sick care industry create a public uproar? Will the old system someday finally crumble?

Now, I’m just a country doctor, but I’m starting to wonder if a system like the one we have can really continue to function much longer.

Hans Duvefelt is a family physician who blogs at A Country Doctor Writes: and the author of A Country Doctor Writes: CONDITIONS: Diseases and Other Life Circumstances.

Image credit: Shutterstock.com

Prev

The impact of COVID on the Hispanic community [PODCAST]

August 7, 2020 Kevin 0
…
Next

Choice is a charged word in medicine

August 8, 2020 Kevin 1
…

Tagged as: Primary Care, Public Health & Policy

Post navigation

< Previous Post
The impact of COVID on the Hispanic community [PODCAST]
Next Post >
Choice is a charged word in medicine

ADVERTISEMENT

More by Hans Duvefelt, MD

  • The art of asking where it hurts

    Hans Duvefelt, MD
  • Thinking like a plumber when adjusting medications

    Hans Duvefelt, MD
  • The American food conspiracy

    Hans Duvefelt, MD

Related Posts

  • Using low-dose naltrexone to treat pain

    Alex Smith
  • 5 hidden consequences of chronic pain

    Toni Bernhard, JD
  • On the internet, you are looking for something to make you angry

    Judson Ellis
  • Chronic disease is making medical education worse

    Jason J. Han, MD
  • As a medical student, you find potential patients everywhere

    Daniel Azzam and Ajay N. Sharma
  • 5 things I wish I had known earlier about chronic pain

    Tom Bowen

More in Conditions

  • AI in prior authorization: the new gatekeeper

    Tiffiny Black, DM, MPA, MBA
  • How to keep the soul of medicine alive in a scaling system

    Gerald Kuo
  • How to handle medical gaslighting

    Alan P. Feren, MD
  • Gender bias in medicine: Who deserves to be saved?

    Anonymous
  • Tick-borne disease vaccines: a 2025 update

    Melvin Sanicas, MD
  • AI and human connection: an ethical crisis

    Mohammed Umer Waris, MD
  • Most Popular

  • Past Week

    • The loss of community pharmacy expertise

      Muhammad Abdullah Khan | Conditions
    • Accountable care cooperatives: a community-owned health care fix

      David K. Cundiff, MD | Policy
    • Psychiatrists are physicians: a key distinction

      Farid Sabet-Sharghi, MD | Physician
    • Valuing non-procedural physician skills

      Jennifer P. Rubin, MD | Physician
    • How genetic testing redefines motherhood [PODCAST]

      The Podcast by KevinMD | Podcast
    • A pediatrician’s reckoning with applied behavior analysis [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Patient modesty in health care matters

      Misty Roberts | Conditions
    • The U.S. gastroenterologist shortage explained

      Brian Hudes, MD | Physician
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
  • Recent Posts

    • A pediatrician’s reckoning with applied behavior analysis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Is primary care becoming a triage station?

      J. Leonard Lichtenfeld, MD | Physician
    • Violence against physicians and the role of empathy

      Dr. R.N. Supreeth | Physician
    • The impact of policy cuts on ableism in health care

      Ahna Shome, MD | Policy
    • How deprescribing in psychiatry offers a path to safer care

      Muhamad Aly Rifai, MD | Meds
    • AI in prior authorization: the new gatekeeper

      Tiffiny Black, DM, MPA, MBA | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The loss of community pharmacy expertise

      Muhammad Abdullah Khan | Conditions
    • Accountable care cooperatives: a community-owned health care fix

      David K. Cundiff, MD | Policy
    • Psychiatrists are physicians: a key distinction

      Farid Sabet-Sharghi, MD | Physician
    • Valuing non-procedural physician skills

      Jennifer P. Rubin, MD | Physician
    • How genetic testing redefines motherhood [PODCAST]

      The Podcast by KevinMD | Podcast
    • A pediatrician’s reckoning with applied behavior analysis [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Patient modesty in health care matters

      Misty Roberts | Conditions
    • The U.S. gastroenterologist shortage explained

      Brian Hudes, MD | Physician
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
  • Recent Posts

    • A pediatrician’s reckoning with applied behavior analysis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Is primary care becoming a triage station?

      J. Leonard Lichtenfeld, MD | Physician
    • Violence against physicians and the role of empathy

      Dr. R.N. Supreeth | Physician
    • The impact of policy cuts on ableism in health care

      Ahna Shome, MD | Policy
    • How deprescribing in psychiatry offers a path to safer care

      Muhamad Aly Rifai, MD | Meds
    • AI in prior authorization: the new gatekeeper

      Tiffiny Black, DM, MPA, MBA | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

There is endless profit potential to treat chronic diseases
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...